Jacqueline Bohn to Receptor, ErbB-2
This is a "connection" page, showing publications Jacqueline Bohn has written about Receptor, ErbB-2.
Connection Strength
0.045
-
Trastuzumab with carboplatin/paclitaxel for treatment of advanced stage and recurrent uterine papillary serous carcinoma: A cost-effectiveness analysis. Gynecol Oncol. 2021 01; 160(1):214-218.
Score: 0.045